Assessment of Electrophysiological Effects of Dabigatran Etexilate as Single Dose on the QT Interval in Healthy Female and Male Subjects.

NCT02170987 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Dabigatran etexilate low
DRUG: Dabigatran etexilate high
DRUG: Moxifloxacin
DRUG: Placebo

Sponsor

Boehringer Ingelheim